Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?

By De Martin Eleonora   Rodriguez-Castro Kryssia I   Vitale Alessandro   Zanus Giacomo   Senzolo Marco   Russo Francesco Paolo   Burra Patrizia  

Future Virology, Vol. 6, Iss. 10, 2011-10 ,pp. : 1179-1186

Future Medicine

Access to resources Recommend Favorite

Liver transplantation for HIV/HCV coinfection: where is the controversy?

By Dannhorn Emily   O'Beirne James P  

Future Virology, Vol. 8, Iss. 7, 2013-07 ,pp. : 639-648

Future Medicine

Access to resources Recommend Favorite

Assessment of health‐related quality of life in Egyptian HCV‐infected recipients after living donor liver transplantation

By  

Journal of Digestive Diseases, Vol. 16, Iss. 11, 2015-11 ,pp. : 675-682

John Wiley & Sons Inc

Access to resources Recommend Favorite

HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations

By  

Current Pharmaceutical Design, Vol. 14, Iss. 17, 2008-06 ,pp. : 1655-1660

Bentham Science Publishers

Access to resources Recommend Favorite

Recurrent hepatitis C virus (HCV) infection after liver transplantation "can be safely treated" with PEG interferon (IFN)- -2b and ribavirin

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite